相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT
Roberto Negro et al.
BLOOD (2012)
Differential transformation capacity of Src family kinases during the initiation of prostate cancer
Houjian Cai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling
Liudmilla Rubbi et al.
SCIENCE SIGNALING (2011)
Lyn- and PLC-β3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease
Wenbin Xiao et al.
BLOOD (2010)
LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer
Yoon-La Choi et al.
CANCER RESEARCH (2010)
Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
Falko Hochgraefe et al.
CANCER RESEARCH (2010)
Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice
Patrizia Scapini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Autoimmune Disease in Lyn-Deficient Mice Is Dependent on an Inflammatory Environment Established by IL-6
Evelyn Tsantikos et al.
JOURNAL OF IMMUNOLOGY (2010)
Functional Analysis of Lyn Kinase A and B Isoforms Reveals Redundant and Distinct Roles in Fc epsilon RI-Dependent Mast Cell Activation
Damiana Avarez-Errico et al.
JOURNAL OF IMMUNOLOGY (2010)
Identification of a novel TEL-Lyn fusion gene in primary myelofibrosis
H. Tanaka et al.
LEUKEMIA (2010)
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Thomas O'Hare et al.
CANCER CELL (2009)
The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice
Sandrine Marchetti et al.
EMBO JOURNAL (2009)
Lyn Kinase Controls Basophil GATA-3 Transcription Factor Expression and Induction of Th2 Cell Differentiation
Nicolas Charles et al.
IMMUNITY (2009)
Multiple roles of Lyn kinase in myeloid cell signaling and function
Patrizia Scapini et al.
IMMUNOLOGICAL REVIEWS (2009)
The tyrosine kinase network regulating mast cell activation
Alasdair M. Gilfillan et al.
IMMUNOLOGICAL REVIEWS (2009)
Csk-binding protein can regulate Lyn signals controlling cell morphology
Evan Ingley
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
A Kinase-Dead Allele of Lyn Attenuates Autoimmune Disease Normally Associated with Lyn Deficiency
Anne M. Verhagen et al.
JOURNAL OF IMMUNOLOGY (2009)
A Conserved Salt Bridge in the G Loop of Multiple Protein Kinases Is Important for Catalysis and for In Vivo Lyn Function
Rina Barouch-Bentov et al.
MOLECULAR CELL (2009)
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
Jinyan Du et al.
NATURE BIOTECHNOLOGY (2009)
Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients
A. K. Samanta et al.
ONCOGENE (2009)
Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells
Ji Wu et al.
BLOOD (2008)
Targeting src family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model
Serk In Park et al.
CANCER RESEARCH (2008)
Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma
Hui Guan et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts
Sebastien Tauzin et al.
BLOOD (2008)
A critical role for Lyn in acute myeloid leukemia
Ceric Dos Santos et al.
BLOOD (2008)
CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation
Venkateswaran Subramaniam et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD
M. Okamoto et al.
LEUKEMIA (2007)
Nonreceptor tyrosine kinases in prostate cancer
Yu-Ming Chang et al.
NEOPLASIA (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E. Geyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Csk-binding protein mediates sequential enzymatic down-regulation and degradation of Lyn in erythropoietin-stimulated cells
Evan Ingley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity
Malcolm A. Meyn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lyn kinase promotes erythroblast expansion and late-stage development
Vinit G. Karur et al.
BLOOD (2006)
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Moshe Talpaz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Lyn kinase activity is the predominant cellular Src kinase activity in glioblastoma tumor cells
AR Stettner et al.
CANCER RESEARCH (2005)
Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the protein
AM Brunati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis
E Ingley et al.
ONCOGENE (2005)
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia
YG Hu et al.
NATURE GENETICS (2004)
Lyn is a target gene for prostate cancer:: Sequence-based inhibition induces regression of human tumor xenografts
M Goldenberg-Furmanov et al.
CANCER RESEARCH (2004)
Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1
KW Harder et al.
BLOOD (2004)
Expression cloning of oligomerization-activated genes with cell-proliferating potency by pseudotype retrovirus vector
A Abe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
SHIP1 and Lyn kinase negatively regulate integrin αIIbβ3 signaling in platelets
MJ Maxwell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase
S Odom et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells
A Ptasznik et al.
NATURE MEDICINE (2004)
Structure and regulation of Src family kinases
TJ Boggon et al.
ONCOGENE (2004)
Src family kinases, key regulators of signal transduction
SJ Parsons et al.
ONCOGENE (2004)
The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged
Q Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
SRC in human carcinogenesis
SV Russello et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Differential effects of quercetin and resveratrol on Band 3 tyrosine phosphorylation signalling of red blood cells
A Maccaglia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases
M Warmuth et al.
BLOOD (2003)
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571
NJ Donato et al.
BLOOD (2003)
Impairment of N-methyl-D-aspartate receptor-controlled motor activity in Lyn-deficient mice
H Umemori et al.
NEUROSCIENCE (2003)
Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity
ML Hibbs et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis
MB Wilson et al.
ONCOGENE (2002)
Substrate conformational restriction and CD45-catalyzed dephosphorylation of tail tyrosine-phosphorylated Src protein
DX Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effect of autophosphorylation on the catalytic and regulatory properties of protein tyrosine kinase Src
GQ Sun et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role of Lyn in the myeloid lineage
KW Harder et al.
IMMUNITY (2001)
Functional analysis of Csk and CHK kinases in breast cancer cells
C Bougeret et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation
F Luciano et al.
ONCOGENE (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF
B Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Expression of B cell receptor-associated signaling molecules in human lupus
S Hucka et al.
AUTOIMMUNITY (2001)
Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling
M Sumitomo et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases
M Kawabuchi et al.
NATURE (2000)
Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation
T Brdicka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
HS1 interacts with Lyn and is critical for erythropoietin-induced differentiation of erythroid cells
E Ingley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
